ISSN: 0305-7372

Journal Home

Journal Guideline

Cancer Treatment Reviews Q1 Unclaimed

W.B. Saunders Ltd United Kingdom

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Cancer Treatment Reviews is a journal indexed in SJR in Medicine (miscellaneous) and Oncology with an H index of 164. It has an SJR impact factor of 3,667 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 3,667.

Cancer Treatment Reviews focuses its scope in these topics and keywords: breast, clinical, kinase, molecular, metastatic, mesotheliomavariability, mechanism, management, malignant, inhibitors, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Medicine (miscellaneous) (Q1) Oncology (Q1) Radiology, Nuclear Medicine and Imaging (Q1)

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

3,667

SJR Impact factor

164

H Index

87

Total Docs (Last Year)

305

Total Docs (3 years)

7857

Total Refs

3415

Total Cites (3 years)

301

Citable Docs (3 years)

9.74

Cites/Doc (2 years)

90.31

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Nature Biomedical Engineering Q1
Journal of Thoracic Oncology Q1
Annual Review of Clinical Psychology Q1
Lancet Digital Health, The Q1
Journal of Experimental Medicine Q1

Compare this journals

Aims and Scope

Best articles by citations

Anastrozole is safer and may be more effective than tamoxifen in postmenopausal women with early-stage breast cancer

The potential of melanoma antigen expression in cancer therapy

Thomas Hodgkin and the museum at Guy's Hospital

Thomas Hodgkin remembered

The sentinel node negative axilla: Is it a no-go zone?

Assessment of response to systemic therapy focusing on metastatic bone disease

Concomitant hydroxyurea plus radiotherapy versus radiotherapy for carcinoma of the uterine cervix: a systematic review

A new look at the original cases of Hodgkin's disease

Letter to the editor

Hereditary nonpolyposis colorectal cancer: preventive management

Evidence-based oncology mitomycin C provides little additional benefit in the treatment of carcinoma of unknown primary site

Genetically modified tumour vaccines -where we are today

SHOW MORE ARTICLES

The management of Hodgkin's disease

Clinical effectiveness of radiotherapy for Hodgkin's lymphoma: a summary .

Clinical effectiveness of radiotherapy for non-Hodgkin's lymphoma: a summary

Oral antibiotic administration and early hospital discharge is a safe and effective alternative for treatment of low-risk neutropenic fever

The role of telomeres in predicting individual radiosensitivity of patients with cancer in the era of personalized radiotherapy

Breast cancer risk following irradiation for Hodgkin's disease

Radiolabeled antibody therapy in non-Hodgkins lymphoma: radiation protection, isotope comparisons and quality of life issues

Photodynamic therapy significantly improves survival outcomes in people with non-resectable cholangiocarcinoma

The current status of FDG-PET in tumour volume definition in radiotherapy treatment planning

Twenty-five years of reviewing cancer treatment

Screening Hodgkin lymphoma survivors for radiotherapy induced cardiovascular disease

Immunotherapy: the last 25 years